John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$251M |
| 2 |
Eli Lilly
LLY
|
+$246M |
| 3 |
Cisco
CSCO
|
+$226M |
| 4 |
Chevron
CVX
|
+$224M |
| 5 |
Mastercard
MA
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$262M |
| 2 |
XYZ
Block Inc
XYZ
|
+$236M |
| 3 |
Target
TGT
|
+$228M |
| 4 |
TJX Companies
TJX
|
+$222M |
| 5 |
Roku
ROKU
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 15.24% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Financials | 8.41% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
POLY
3501
CALL
DELISTED
Plantronics, Inc.
POLY
| $365K | ﹤0.01% |
+14,200
| New | +$446K |
|
3502
i3 Verticals
IIIV
$306M
| $364K | ﹤0.01% |
15,015
-14,047
| -48% | -$405K |
|
3503
PUT
Floor & Decor
FND
$5.78B
| $362K | ﹤0.01% |
3,000
-14,700
| -83% | -$1.75M |
|
|
XELA
3504
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $361K | ﹤0.01% |
+46
| New | +$471K |
|
3505
CALL
Churchill Downs
CHDN
$6.18B
| $360K | ﹤0.01% |
+3,000
| New | +$305K |
|
3506
LSI Industries
LYTS
$758M
| $360K | ﹤0.01% |
46,465
-19,294
| -29% | -$147K |
|
3507
CALL
Northrop Grumman
NOC
$77.1B
| $360K | ﹤0.01% |
1,000
-500
| -33% | -$181K |
|
3508
PUT
Stride
LRN
$3.56B
| $359K | ﹤0.01% |
10,000
-14,900
| -60% | -$489K |
|
3509
PUT
Sinclair Inc
SBGI
$1.06B
| $358K | ﹤0.01% |
11,300
-9,900
| -47% | -$291K |
|
|
TFFP
3510
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $358K | ﹤0.01% |
1,856
-1,915
| -51% | -$406K |
|
|
P
3511
CALL
Everpure Inc
P
$34.2B
| $357K | ﹤0.01% |
14,200
-61,400
| -81% | -$1.36M |
|
|
FMTX
3512
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $357K | ﹤0.01% |
+15,400
| New | +$364K |
|
3513
Arcturus Therapeutics
ARCT
$439M
| $356K | ﹤0.01% |
7,444
-318,049
| -98% | -$14.3M |
|
3514
PUT
Gogo Inc
GOGO
$369M
| $356K | ﹤0.01% |
20,600
-27,400
| -57% | -$332K |
|
3515
National Bankshares
NKSH
$261M
| $355K | ﹤0.01% |
9,775
+881
| +10% | +$32.1K |
|
3516
PUT
SL Green Realty
SLG
$4.24B
| $354K | ﹤0.01% |
+5,000
| New | +$365K |
|
3517
Evolution Petroleum
EPM
$125M
| $353K | ﹤0.01% |
+62,205
| New | +$278K |
|
3518
Larimar Therapeutics
LRMR
$432M
| $353K | ﹤0.01% |
+30,607
| New | +$367K |
|
|
SRG
3519
Seritage Growth Properties
SRG
$119M
| $353K | ﹤0.01% |
23,813
+23
| +0.1% | +$363 |
|
3520
Celcuity
CELC
$4.51B
| $352K | ﹤0.01% |
+19,572
| New | +$415K |
|
3521
PUT
United Rentals
URI
$65.6B
| $351K | ﹤0.01% |
+1,000
| New | +$336K |
|
3522
PUT
Kratos Defense & Security Solutions
KTOS
$9.88B
| $350K | ﹤0.01% |
+15,700
| New | +$388K |
|
3523
LSB Industries
LXU
$740M
| $350K | ﹤0.01% |
44,600
+22,800
| +105% | +$142K |
|
3524
Shift4
FOUR
$3.79B
| $349K | ﹤0.01% |
+4,496
| New | +$388K |
|
3525
PUT
Paychex
PAYX
$44.5B
| $349K | ﹤0.01% |
3,100
-18,300
| -86% | -$2.06M |
|
Similar funds
John Overdeck's Q3 2021 Portfolio in Review
As of Q3 2021, John Overdeck held 4,966 positions worth $44.7B, up 1.5% from $44.1B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
John Overdeck deployed $1.71B of net new capital in Q3 2021, opening 996 new positions and adding to 1,597 existing holdings. Its largest new stake was PayPal: 884,227 shares worth $230M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Block Inc, an estimated $236M trimmed.
- John Overdeck's largest Q3 2021 buy was PayPal: 884,227 shares worth $230M.
- John Overdeck added most to Cisco in Q3 2021, an estimated $226M increase.
- John Overdeck's biggest Q3 2021 reduction was Block Inc, cutting an estimated $236M.
- John Overdeck fully exited Pfizer in Q3 2021, selling an estimated $262M.
- John Overdeck's ten largest holdings make up 5.2% of its $44.7B portfolio in Q3 2021.
- John Overdeck opened 996 new positions and closed 790 in Q3 2021.
- John Overdeck's portfolio value rose 1.5% quarter-over-quarter to $44.7B.
Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.